Market Research Report
Europe Biochips Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||603656|
|Published||Content info||87 Pages
Delivery time: 1-2 business days
|Europe Biochips Market Forecast 2019-2027|
|Published: March 9, 2019||Content info: 87 Pages||
Europe Biochips market stood at $XX million in 2018. By the end of the forecast period of 2019-2027, the market is anticipated to collect $XX million, exhibiting a CAGR of 20.22%. Germany, France, United Kingdom, Spain, Italy and the remaining countries forming the Rest of Europe regional segment are considered for the market analysis.
The biochips market in Europe is driven by government funding to develop and promote the biotechnology sector. Also, factors like increased government funding to develop personalized medicine and rising prevalence of various government initiatives supporting biotechnology are positively influencing the growth of the biochips market in Europe.
The German biochips market is being propelled by various government initiatives and programs to develop and promote biotechnology. On the other hand, the U.K biochip market finds several applications in molecular diagnostics, and in point-of-care diagnosis. France biochips market is mainly driven by funding supporting emerging fields such as cancer biomarkers, genomic studies and rise in diagnosis & treatment of cancer, while the Italian market is driven by rising investments in personalized medicines and genomics. The initiation of several government initiatives supporting biotechnology and technological advancements in biochip technology are driving the rapid integration of biochips technology in the market for the Rest of Europe regional segment.
Some of the competing players in this market are Cepheid Inc., Bio-Rad Laboratories Inc., bioMerieux SA, Cybrdi Inc., Merck GmbH, OriGene Technologies Inc., IMGENEX, PerkinElmer Inc., Biochain Institute Inc., Thermo Fisher Scientific Inc., Samsung Electronics Inc., Fluidigm Corporation, Gamida for Life Group, Illumina Inc. and Agilent Technology Inc.